Assessing Finasteride-Associated Sexual Dysfunction Using the FAERS Database

The study analyzed the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database to determine whether the use of finasteride, a medication used to treat hair loss and benign prostatic hyperplasia, is associated with an increased risk of sexual dysfunction. The study found a significant association between finasteride use and sexual dysfunction, with a higher risk in younger age groups. The study suggests that healthcare providers should inform patients about the potential risk of sexual dysfunction associated with finasteride use.